The story of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its dominance. While certain pharmaceutical companies may attempt to capitalize on male sexu